Loading organizations...
Drug research and development company with various laboratories.
TYK Medicines has raised $130.1M across 3 funding rounds.
TYK Medicines has raised $130.1M in total across 3 funding rounds.
TYK Medicines has raised $130.1M in total across 3 funding rounds.
TYK Medicines's investors include Sunshine Riverhead Capital.
TYK Medicines has raised $130.1M across 3 funding rounds. Most recently, it raised $28.1M Series D in December 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 28, 2023 | $28.1M Series D | ||
| May 24, 2021 | $62.2M Series B | ||
| Dec 15, 2020 | $39.8M Series B | Sunshine Riverhead Capital |